Emergent BioSolutions (EBS) EV to EBITDA (2011 - 2026)
Emergent BioSolutions (EBS) posted EV to EBITDA of 2.31 for Q2 2026, down 109.04% on a QoQ basis from 25.57 in Q1 2026, and down 105.16% year-over-year from 44.75 in Q2 2025.
Powered by 
Analysis
Emergent BioSolutions (EBS) EV to EBITDA (2011 - 2026) Analysis & Trends
Emergent BioSolutions has reported EV to EBITDA for 16 years, with the latest figure at 2.31 in Q2 2026.
- On a quarterly basis, EV to EBITDA fell 105.16% year-over-year to 2.31 in Q2 2026; TTM through Jun 2026 was 4.38, a 751.25% decrease from a year earlier, with the FY2025 full-year figure at 4.34, up 214.2% from the prior year.
- EV to EBITDA was 2.31 for Q2 2026 at Emergent BioSolutions, down from 25.57 in the prior quarter.
- The five-year high for EV to EBITDA was 236.73 in Q1 2022, with the low at 43.53 in Q4 2024.
- Average EV to EBITDA over 5 years is 12.24, with a median of 0.34 recorded in 2023.
- The sharpest annual moves came in 2024 and 2025: EV to EBITDA sank 13938.95% in 2024, then soared 3242.88% in 2025.
- Over 5 years, EV to EBITDA stood at 0.92 in 2022, then slumped by 133.67% to 0.31 in 2023, then tumbled by 13938.95% to 43.53 in 2024, then jumped by 64.19% to 15.59 in 2025, then jumped by 85.18% to 2.31 in 2026.
- The last three EV to EBITDA figures came in at 2.31 (Q2 2026), 25.57 (Q1 2026), and 15.59 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.31 |
| Mar 31, 2026 | 25.57 |
| Dec 31, 2025 | -15.59 |
| Sep 30, 2025 | 2.82 |
| Jun 30, 2025 | 44.75 |
| Mar 31, 2025 | 2.25 |
| Dec 31, 2024 | -43.53 |
| Sep 30, 2024 | 4.58 |
| Jun 30, 2024 | -1.42 |
| Mar 31, 2024 | 1.35 |
| Dec 31, 2023 | -0.31 |
| Sep 30, 2023 | -0.36 |
| Jun 30, 2023 | -1.00 |
| Mar 31, 2023 | -0.62 |
| Dec 31, 2022 | 0.92 |
| Sep 30, 2022 | -17.80 |
| Jun 30, 2022 | -15.60 |
| Mar 31, 2022 | 236.73 |
| Dec 31, 2021 | 5.77 |
| Sep 30, 2021 | -51.11 |
API Access
Emergent BioSolutions EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();